ANI Pharmaceuticals | Attività Correnti



Current Assets Cambiamento Data
AbbVie USD 25.58B 2.2B 2024-12
ANI Pharmaceuticals USD 527.68M 6.39M 2024-12
Aurora Cannabis CAD 494.21M 76.54M 2024-12
Canopy Growth CAD 341.08M 50.58M 2024-12
Eli Lilly USD 32.74B 1.32B 2024-12
Hikma Pharmaceutical USD 2.28B 185M 2024-06
Knight Therapeutics CAD 397.57M 36.96M 2024-09
Novartis USD 29.7B 1.56B 2024-12
Perrigo USD 2.48B 1.23B 2024-12
Sun Pharmaceuticals INR 461.05B 26.3B 2024-09
Teva Pharmaceutical Industries USD 12.55B 238M 2024-12



ANI Pharmaceuticals Attività Correnti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Apr 2025.